Partial
Partially Aligned
Patient Risk:
Moderate
Summary
Claims about ibuprofen GI bleeding risk and certain caution populations are partially supported by the provided label sections, but the majority of claims are doxycycline-specific interaction/administration/timing/absorption statements that are not supported by the provided label text.
Category Scores
Accurate Statements
Ibuprofen bleeding risk is increased especially at higher doses, longer use, or with alcohol.
WARNINGS (Gastrointestinal Effects - Risk of Ulceration, Bleeding and Perforation)
People with a history of stomach ulcers or gastrointestinal bleeding may need to avoid or be extra cautious with ibuprofen.
WARNINGS (Gastrointestinal Effects - Risk of Ulceration, Bleeding and Perforation)
People taking blood thinners or other medicines that increase bleeding risk may need to avoid or be extra cautious with ibuprofen.
WARNINGS (Gastrointestinal Effects - Risk of Ulceration, Bleeding and Perforation); DRUG INTERACTIONS (Warfarin-type anticoagulants)
Unsupported Statements
Ibuprofen and doxycycline are not known for a direct interaction that makes the combination unsafe for most people.
No provided label section mentions doxycycline or any ibuprofen–doxycycline interaction.
There is no well-established evidence that ibuprofen reduces doxycycline’s effectiveness.
No provided label section discusses doxycycline effectiveness or any ibuprofen–doxycycline interaction.
Doxycycline commonly causes stomach upset and nausea.
No provided label section includes doxycycline adverse effects.
Severe stomach pain, vomiting blood, black/tarry stools, or feeling faint when combining ibuprofen with doxycycline warrant urgent medical care.
Provided sections discuss GI ulceration/bleeding monitoring with NSAID therapy, but do not include the doxycycline combination context or this specific symptom list/urgent-care instruction.
Acetaminophen (paracetamol) is often a safer first choice for pain/fever than NSAIDs like ibuprofen for some patients.
No provided label section discusses acetaminophen/paracetamol or comparative safety vs NSAIDs.
No special timing is required for ibuprofen when taking doxycycline.
No provided label section addresses timing with doxycycline or any ibuprofen–doxycycline administration guidance.
Doxycycline instructions should be followed, including taking doxycycline with a full glass of water.
No provided label section includes doxycycline administration instructions.
After taking doxycycline, staying upright for about 30 minutes helps reduce irritation.
No provided label section includes doxycycline-specific posture/timing instructions.
Taking doxycycline at the same time as certain minerals (iron, calcium, magnesium) and some antacids can reduce doxycycline absorption.
No provided label section discusses doxycycline absorption or interactions with minerals/antacids.
Contradictions
Low
AI Statement
People with significant heart disease or uncontrolled high blood pressure may need to avoid or be extra cautious with ibuprofen.
Label Reference
WARNINGS (Hypertension; Cardiovascular Thrombotic Events; Avoid the use in recent MI; Avoid the use in severe heart failure) indicates caution/avoidance and monitoring, but does not specifically use the phrase 'uncontrolled high blood pressure' (so this is not a direct contradiction).
Important Omissions
Doxycycline-specific FDA-label details related to administration/timing/positioning and absorption-lowering interactions were not evaluated because no doxycycline label text was provided.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Several ibuprofen safety/caution statements are label-consistent, but multiple doxycycline-specific interaction and administration/timing claims are unsupported by the provided label text, which could lead to inaccurate guidance.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Partially Aligned
Primary Issue
Most doxycycline-related claims are not supported by the provided ibuprofen label sections (doxycycline label content not included). Several statements therefore cannot be confirmed against the official FDA-approved prescribing information provided.
Suggested Improvement
Remove or revise doxycycline-specific interaction, administration (water quantity, upright time), and mineral/antacid absorption claims unless the corresponding doxycycline FDA label sections are supplied; keep only ibuprofen claims that are directly supported by the provided ibuprofen label text.